Pfizer Announces a Research Grant RFP

2023 Growth Hormone ResearchCompetitive Grant Program - internal Pfizer review process
I. BackgroundPfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives(e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet
medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP)
that provides detail regarding a general area of interest, sets timelines for review and approval, and uses
an internal Pfizer review process to make final grant decisions. Organizations are invited to submit anapplication addressing the research gaps as outlined in the specific RFP.
For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (andultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of theindependent initiative supported by the grant, including compliance with any regulatory requirements.
Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct ormonitoring of the research program. An ISR grant request cannot be submitted for a study that has
already commenced and was not originally supported by Pfizer.

32023Growth Hormone ResearchII. Eligibility
Geographic Scope:

GlobalApplicant Eligibility
Criteria•

The institution and principal investigator (PI) must be based in one of theeligible countries noted above.

•Only organizations are eligible to receive grants, not individuals or
medical practice groups.

•The applicant (PI) must have a medical or postdoctoral degree (MD,PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD),
or a degree in Pharmacy, Physiotherapy, or Social Work.

•Applicant must be affiliated with a host institution.

•Pfizer believes that every person deserves to be seen, heard, and caredfor, and we work to further this goal by encouraging grant requestors withdifferent backgrounds, perspectives, and experiences to apply.

Date RFP Issued•

13 September 2022

Clinical Area•

Short Stature/growth failure

General Area of Interestfor this RFP:

Research projects that will be considered for Pfizer support will advance themedical knowledge of short stature.

III. Requirements

Projects submitted may include:
••••
•••

Morbidities in growth disorders
Strategies to evaluate and treat growth disorders including Quality ofLife and Patient Reported Outcomes
Comparative pathophysiology of daily vs long-acting growth hormone
Evaluation of adherence of daily and long-acting growth hormone
treatment
Novel strategies to address current unmet medical needs in shortstature management which could be addressed with long-acting growth
hormone treatment
Comparison of clinical effects of daily vs long-acting growth hormone
Projects may include basic, translational or clinical research(Note for clinical research studies requesting drug supply: Drug supply
refers only to those countries where a drug has regulatory marketing
authorization and commercial stock supply is available).

132023Growth Hormone Research

Expected Approximate
Monetary Range ofGrant Applications:•Individual projects requesting up to $150,000 will be considered. Pfizer
anticipates awarding a minimum of 2 projects.

Key Dates:•RFP release date: 13 September 2022•

Grant Application due date: 13 February 2023

•Anticipated Grant Award Notification Date: April 2023•

Funds will be distributed following a fully executed agreement andsubmission of Final Protocol, documentation of IRB/IEC approval,regulatory approval (if applicable), exemption or waiver.

•Anticipated Project Start and End Dates: on or after October 2023•

Please go www.cybergrants.com/pfizer/Research and sign in. First-timeusers should click “Create your password”. [Note: there are individual

How to Submit:

portals for each grant application type. Please be sure to use the URL above.]•Click the “Start A New Research Grant Application” button.

•In the application:oo

For the question “Competitive Grant?” select Yes
Select the following Competitive Grant Program Name: 2023 RD
G - Growth Hormone Research•

Requirements for submission:
Complete all required sections of the online application and upload yourproject proposal (see Appendix) in the Proposal/Protocol field.

•If you encounter any technical difficulties with the website, please click
the “Technical Questions” link at the bottom of the page.

IMPORTANT: Be advised applications submitted after the due date will not
be reviewed.

Questions:Grant Agreements:•If you have questions regarding this RFP, please direct them in writing
to the Grant Officer, Amanda Stein (amanda.j.stein@pfizer.com), withthe subject line “2023 RD G - Growth Hormone Research”•Please click here to view Frequently Asked Questions regarding theCompetitive Grant Program•

If your grant is approved, your institution will be required to enter into awritten grant agreement with Pfizer. Please click here to view the coreterms of the agreement.
Pfizer has drafted the terms of these agreements to be balanced andreasonable and to further the goals of both parties. Negotiating grant•2

32023Growth Hormone Research

agreements requires significant resources, so please ensure that yourinstitution (including your legal department) is able and willing to abideby these terms before proceeding with submission of your application as
they will need to be accepted in their entirety.

Review and Approval
Process•

Grant requests received in response to a general RFP are reviewed by
Pfizer to make final grant decisions.

Mechanism by whichApplicants will beNotified:••All applicants will be notified via email by the dates noted above.
Applicants may be asked for additional clarification during the review
period.

332023
Growth Hormone ResearchAppendix A

General RFP Submission Requirements
Project Proposals/Protocols should be single-spaced using Calibri 12-point font and 1-inch
margins. Note there is a 12-page limit exclusive of references. Please include the following:
Goals and Objectives•

Provide the main goal of the study and the study population (ifapplicable). Provide a detailed definition that is directly linked to theprimary objective

Assessment of Needfor the Project•This should reflect your study rationale. Provide a brief description of the
medical/scientific question and the rationale of how this trial or study
addresses the question

Target Audience•Describe the primary audience(s) targeted for this project. For
Investigator Sponsored Clinical Trials, please specify the age, genderand other demographic information for trial population•

Also indicate whom you believe will directly benefit from the project
outcomes. Describe the overall population size as well as the size of yoursample population•Describe concisely the research design and methods for achieving thestated goals. For a clinical interventional study, include
inclusion/exclusion criteria, treatment plan and statistical plan•

Please describe how the project submitted supports diversity, equity, andinclusion either through the study population targeted or through theproject team that is directly involved

Innovation•Explain what measures you have taken to assure that this project idea isoriginal and does not duplicate other projects. Describe how this projectbuilds upon existing work, pilot projects, or ongoing projects developed
either by your institution or other institutions related to this projectEvaluation andOutcomes•Specify type and frequency of safety, efficacy, and/or outcome
measures. Also indicate the method(s) used to assess measures•

Provide a publication plan describing intended submission of abstracts to(a) congress(es) or intended submission of (a) publication(s) to peerreviewed journals.

•Provide an anticipated timeline for your project including project start/end
dates

Project Design andMethods

Anticipated ProjectTimelineoAn ISR grant request cannot be submitted for a study that has
already commenced and was not originally supported by Pfizer.

432023
Growth Hormone Research

Additional Information•

If there is any additional information you feel Pfizer should be aware ofconcerning the importance of this project, please summarize here•

Early-career applicants: Letter(s) of support from mentor(s) andcollaborators describing how the award will advance the applicant’scareer.

Organization Detail•This information is used to assess the capability of the organizational
resources available to perform the effort proposed. Identify the facilities
to be used [laboratory, animal, clinical and “other”]. If appropriate,indicate their capacities, pertinent capabilities, relative proximity andextent of availability to the project

Budget Detail•

While estimating your budget please keep the following items in mind:•oGeneral organizational running costs such as insurances, heating,lighting, rent, building maintenance may be included. Pfizer does
not provide funding for capital purchases (infrastructure expenses
such as equipment, purchases of software or software licenses,
technology or bricks and mortar). Equipment hire/leasing is
acceptable and may be included in project budget.

oThe inclusion of these costs cannot cause the amount requested
to exceed the budget limit set forth in the RFP.

oIt should be noted that grants awarded through GMG cannot be
used to purchase Pfizer therapeutic agents (prescription or nonprescription).

Pfizer maintains a company-wide, maximum allowed overhead rate of
28% for independent studies and projects. Please click here fordetails.
References•Bibliography of relevant references.

5